Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

1.74
Delayed Data
As of Feb 16
 +0.015 / +0.87%
Today’s Change
1.35
Today|||52-Week Range
4.69
+2.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$35.6M

Company Description

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Contact Information

Imprimis Pharmaceuticals, Inc.
12264 El Camino Real
San Diego California 92130
P:(858) 704-4040
Investor Relations:

Employees

Shareholders

Mutual fund holders4.11%
Individual stakeholders19.44%
Other institutional13.19%

Top Executives

Mark L. BaumChief Executive Office & Director
Andrew R. BollCFO, Secretary & Principal Accounting Officer
David MoufarregeVice President-Technology
John P. SaharekChief Commercial Officer